AUPR879401A0 - Novel chemical compounds and their use - Google Patents

Novel chemical compounds and their use

Info

Publication number
AUPR879401A0
AUPR879401A0 AUPR8794A AUPR879401A AUPR879401A0 AU PR879401 A0 AUPR879401 A0 AU PR879401A0 AU PR8794 A AUPR8794 A AU PR8794A AU PR879401 A AUPR879401 A AU PR879401A AU PR879401 A0 AUPR879401 A0 AU PR879401A0
Authority
AU
Australia
Prior art keywords
chemical compounds
novel chemical
amino
compounds
trifluoroacetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR8794A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Priority to AUPR8794A priority Critical patent/AUPR879401A0/en
Publication of AUPR879401A0 publication Critical patent/AUPR879401A0/en
Priority to PCT/AU2002/001527 priority patent/WO2003040137A1/en
Priority to EP02771913A priority patent/EP1451181B1/en
Priority to PT02771913T priority patent/PT1451181E/pt
Priority to AU2002336823A priority patent/AU2002336823B2/en
Priority to DE60227409T priority patent/DE60227409D1/de
Priority to CNB028222482A priority patent/CN100526309C/zh
Priority to JP2003542183A priority patent/JP2005508989A/ja
Priority to CA2463865A priority patent/CA2463865C/en
Priority to DK02771913T priority patent/DK1451181T3/da
Priority to US10/494,260 priority patent/US7223790B2/en
Priority to AT02771913T priority patent/ATE399780T1/de
Priority to ES02771913T priority patent/ES2307793T3/es
Priority to KR1020047006447A priority patent/KR101002794B1/ko
Priority to HK05100553.4A priority patent/HK1068347B/en
Priority to US11/734,394 priority patent/US7468388B2/en
Priority to JP2010161620A priority patent/JP2011016804A/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AUPR8794A 2001-11-09 2001-11-09 Novel chemical compounds and their use Abandoned AUPR879401A0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
AUPR8794A AUPR879401A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use
HK05100553.4A HK1068347B (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
CA2463865A CA2463865C (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
US10/494,260 US7223790B2 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
PT02771913T PT1451181E (pt) 2001-11-09 2002-11-08 Compostos diméricos e sua utilização como agentes antivirais
AU2002336823A AU2002336823B2 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
DE60227409T DE60227409D1 (de) 2001-11-09 2002-11-08 Dimere verbindungen und deren verwendung als antivirale mittel
CNB028222482A CN100526309C (zh) 2001-11-09 2002-11-08 二聚化合物及其作为抗病毒剂的应用
JP2003542183A JP2005508989A (ja) 2001-11-09 2002-11-08 二量体化合物および抗ウイルス薬としてのそれらの使用
PCT/AU2002/001527 WO2003040137A1 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
DK02771913T DK1451181T3 (da) 2001-11-09 2002-11-08 Dimere forbindelser og deres anvendelse som antivirale midler
EP02771913A EP1451181B1 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
AT02771913T ATE399780T1 (de) 2001-11-09 2002-11-08 Dimere verbindungen und deren verwendung als antivirale mittel
ES02771913T ES2307793T3 (es) 2001-11-09 2002-11-08 Compuestos dimericos y su utilizacion como agentes antiviricos.
KR1020047006447A KR101002794B1 (ko) 2001-11-09 2002-11-08 이량체 화합물 및 항바이러스제로서의 그의 용도
US11/734,394 US7468388B2 (en) 2001-11-09 2007-04-12 Dimeric compounds and their use as anti-viral agents
JP2010161620A JP2011016804A (ja) 2001-11-09 2010-07-16 二量体化合物および抗ウイルス薬としてのそれらの使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR8794A AUPR879401A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use

Publications (1)

Publication Number Publication Date
AUPR879401A0 true AUPR879401A0 (en) 2001-12-06

Family

ID=3832613

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR8794A Abandoned AUPR879401A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use

Country Status (13)

Country Link
US (2) US7223790B2 (enExample)
EP (1) EP1451181B1 (enExample)
JP (2) JP2005508989A (enExample)
KR (1) KR101002794B1 (enExample)
CN (1) CN100526309C (enExample)
AT (1) ATE399780T1 (enExample)
AU (1) AUPR879401A0 (enExample)
CA (1) CA2463865C (enExample)
DE (1) DE60227409D1 (enExample)
DK (1) DK1451181T3 (enExample)
ES (1) ES2307793T3 (enExample)
PT (1) PT1451181E (enExample)
WO (1) WO2003040137A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4535713B2 (ja) * 2003-10-30 2010-09-01 株式会社ヤクルト本社 抗ヒトサイトメガロウイルス剤
US20070094334A1 (en) * 2005-10-21 2007-04-26 Microsoft Corporation Service/client synchronization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
KR19990087449A (ko) * 1996-03-01 1999-12-27 리차드 웨드레이 인플루엔자 바이러스의 검출방법 및 이에 이용되는 화합물
TR199901081T2 (xx) 1996-11-14 1999-08-23 Biota Scientific Management Pty.Ltd. Y�ntem ve bu y�ntemde kullan�lan yeni bile�imler.
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Also Published As

Publication number Publication date
CN100526309C (zh) 2009-08-12
HK1068347A1 (en) 2005-04-29
CA2463865C (en) 2011-09-27
KR20050044340A (ko) 2005-05-12
ES2307793T3 (es) 2008-12-01
PT1451181E (pt) 2008-10-01
WO2003040137A1 (en) 2003-05-15
EP1451181B1 (en) 2008-07-02
EP1451181A1 (en) 2004-09-01
US20070225358A1 (en) 2007-09-27
ATE399780T1 (de) 2008-07-15
EP1451181A4 (en) 2005-02-02
US7468388B2 (en) 2008-12-23
JP2011016804A (ja) 2011-01-27
US7223790B2 (en) 2007-05-29
CA2463865A1 (en) 2003-05-15
CN1585766A (zh) 2005-02-23
JP2005508989A (ja) 2005-04-07
DE60227409D1 (de) 2008-08-14
US20050054719A1 (en) 2005-03-10
KR101002794B1 (ko) 2010-12-21
DK1451181T3 (da) 2008-11-03

Similar Documents

Publication Publication Date Title
CA2086654A1 (en) Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
IL205420A (en) Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders
CA2312885A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
AP1475A (en) Trisubstituted 1, 3, 5-triazine derivatives for treatment of HIV infections.
GEP20053619B (en) Pyrazole Derivatives for Treating HIV
NO20060706L (no) Inhibitorer av serinproteaser, spesielt HCV NS3-NS4A-protease
AP1739A (en) Azaindoles
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
EP0368640A3 (en) Heterocyclic compounds
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE60318874D1 (en) Pyrazolderivate
AUPR879401A0 (en) Novel chemical compounds and their use
YU92003A (sh) Karbapenem jedinjenje
AUPR879501A0 (en) Novel chemical compounds and their use
EP1078635A3 (en) Medicaments comprising sialic acid derivatives as active ingredients
EP1541562A4 (en) NEW URACIL DERIVATIVES AND THEIR MEDICAL USE
ATE301997T1 (de) Antivirale therapie
GB0223234D0 (en) Chemical compounds
WO2004065411A3 (en) Peptides
AU4485101A (en) Antiviral therapy
PL304334A1 (en) Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract
GB0125658D0 (en) Medicaments
MXPA04000188A (es) Azaindoles.